The Cigna Group (NYSE:CI) Shares Sold by Wrapmanager Inc.

Wrapmanager Inc. trimmed its holdings in The Cigna Group (NYSE:CI) by 6.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 708 shares of the health services provider’s stock after selling 51 shares during the quarter. Wrapmanager Inc.’s holdings in The Cigna Group were worth $212,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently bought and sold shares of CI. Bogart Wealth LLC raised its stake in shares of The Cigna Group by 104.5% during the 3rd quarter. Bogart Wealth LLC now owns 90 shares of the health services provider’s stock worth $26,000 after purchasing an additional 46 shares in the last quarter. OFI Invest Asset Management acquired a new stake in The Cigna Group in the third quarter valued at approximately $26,000. Fortitude Family Office LLC bought a new stake in The Cigna Group in the fourth quarter worth approximately $29,000. VisionPoint Advisory Group LLC increased its stake in shares of The Cigna Group by 112.2% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 104 shares of the health services provider’s stock worth $30,000 after purchasing an additional 55 shares during the last quarter. Finally, Pacifica Partners Inc. raised its holdings in shares of The Cigna Group by 73.2% during the 4th quarter. Pacifica Partners Inc. now owns 142 shares of the health services provider’s stock valued at $43,000 after purchasing an additional 60 shares in the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other The Cigna Group news, CEO David Cordani sold 2,073 shares of the stock in a transaction on Monday, February 12th. The shares were sold at an average price of $336.81, for a total value of $698,207.13. Following the completion of the sale, the chief executive officer now owns 329,321 shares in the company, valued at $110,918,606.01. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other The Cigna Group news, CEO David Cordani sold 2,073 shares of the stock in a transaction on Monday, February 12th. The shares were sold at an average price of $336.81, for a total value of $698,207.13. Following the completion of the sale, the chief executive officer now owns 329,321 shares in the company, valued at $110,918,606.01. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Eric P. Palmer sold 6,083 shares of the stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $340.00, for a total transaction of $2,068,220.00. Following the completion of the transaction, the insider now directly owns 44,649 shares in the company, valued at $15,180,660. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 70,195 shares of company stock worth $24,586,775. 0.70% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research firms have recently commented on CI. Wells Fargo & Company lifted their price target on shares of The Cigna Group from $334.00 to $348.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 6th. Cantor Fitzgerald lifted their target price on shares of The Cigna Group from $384.00 to $400.00 and gave the stock an “overweight” rating in a report on Friday, May 3rd. Mizuho lifted their target price on shares of The Cigna Group from $360.00 to $370.00 and gave the stock a “buy” rating in a report on Monday, February 5th. Royal Bank of Canada upgraded shares of The Cigna Group from a “sector perform” rating to an “outperform” rating and lifted their target price for the stock from $327.00 to $354.00 in a report on Monday, February 5th. Finally, Oppenheimer lifted their target price on shares of The Cigna Group from $370.00 to $400.00 and gave the stock an “outperform” rating in a report on Friday, May 3rd. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, The Cigna Group presently has an average rating of “Buy” and a consensus target price of $366.14.

The Cigna Group Trading Down 0.7 %

Shares of CI traded down $2.57 on Friday, reaching $348.40. 1,675,306 shares of the company’s stock were exchanged, compared to its average volume of 1,586,253. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.75. The stock has a market capitalization of $98.97 billion, a P/E ratio of 28.60, a price-to-earnings-growth ratio of 1.04 and a beta of 0.57. The business has a 50 day moving average price of $351.44 and a two-hundred day moving average price of $320.62. The Cigna Group has a 12 month low of $240.50 and a 12 month high of $365.71.

The Cigna Group (NYSE:CI) last issued its earnings results on Thursday, May 2nd. The health services provider reported $6.47 EPS for the quarter, beating the consensus estimate of $6.17 by $0.30. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The firm had revenue of $57.25 billion during the quarter, compared to the consensus estimate of $56.59 billion. During the same quarter in the prior year, the firm earned $5.41 earnings per share. The business’s quarterly revenue was up 23.2% on a year-over-year basis. Research analysts anticipate that The Cigna Group will post 28.45 earnings per share for the current year.

The Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 20th. Investors of record on Tuesday, June 4th will be issued a dividend of $1.40 per share. This represents a $5.60 annualized dividend and a yield of 1.61%. The ex-dividend date is Tuesday, June 4th. The Cigna Group’s payout ratio is 45.98%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.